SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-20-000028
Filing Date
2020-07-30
Accepted
2020-07-30 19:04:09
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20200630.htm   iXBRL 10-Q 1623132
2 EX-3.1 restatedcertificateofi.htm EX-3.1 65916
3 EX-31.1 ex-311q22020.htm EX-31.1 10377
4 EX-31.2 ex-312q22020.htm EX-31.2 11450
5 EX-32.1 ex-321q22020.htm EX-32.1 5817
6 EX-32.2 ex-322q22020.htm EX-32.2 5860
  Complete submission text file 0001113148-20-000028.txt   6001032

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20200630.xsd EX-101.SCH 53263
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20200630_cal.xml EX-101.CAL 77718
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20200630_def.xml EX-101.DEF 207165
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20200630_lab.xml EX-101.LAB 509573
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20200630_pre.xml EX-101.PRE 309041
12 EXTRACTED XBRL INSTANCE DOCUMENT infi-20200630_htm.xml XML 845405
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 201061779
SIC: 2834 Pharmaceutical Preparations